News and Analysis | Published:

Food allergy drugs step up to Phase III

Nature Reviews Drug Discovery volume 15, pages 149150 (2016) | Download Citation

Two biotechs have carved out a regulatory pathway for what could become the first FDA-approved preventative peanut allergy therapies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd.2016.24

Authors

  1. Search for Katie Kingwell in:

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing